JusticeItaly Official institution
Italy changes marketing permission for Medivid medicine
Italy's medicines agency AIFA has published a notice on 3 November 2026 saying the marketing permission for the human medicine Medivid has been changed. The excerpt does not say what the change is, so the details are only available in the full notice. Marketing permission is the official approval that allows a medicine to be sold in Italy.
This summary was generated by AI; the official source prevails.
What does it mean?
Italy's medicine regulator has officially changed the permission that lets the medicine Medivid be sold. The notice itself does not say what changed, so the full notice is needed for details.
Who is affected?
Patients who use Medivid and the companies that sell or hold the approval for it.